Influenza — Patent Landscape

Aggregated US Orange Book patent estate across every approved drug for influenza. 54 active patents protecting 1 drugs from 1+ originators. First major cliff: 2030. Daily refresh.

1
Approved drugs
54
Active US patents
42/100
Avg vulnerability
—
Annual revenue covered

Originators in Influenza

Companies holding active patents on drugs approved for this indication. Click through to each company's full patent dashboard.

Roche 54 patents

Cliff calendar — next 15 years

Patent expiries per year across all drugs treating influenza. Each bar = one year. Y-axis scaled to peak year (12 patents).

6
30
6
31
6
32
12
36
12
37
6
38
3
39
3
41

Approved drugs ranked by patent estate

Drug Originator Active patents Avg vuln Revenue First cliff
Xofluza
BALOXAVIR MARBOXIL
 Roche 54 42 — 2030-06-14

Most attackable patents

Highest vulnerability scores in the indication — paragraph IV / IPR / design-around candidates.

Patent Drug Type Vuln Expiry
10633397 Xofluza method of use 75 2036-04-27
10633397 Xofluza method of use 75 2036-04-27
11306106 Xofluza method of use 75 2037-08-09
11306106 Xofluza method of use 75 2037-08-09
11306106 Xofluza method of use 70 2037-08-09
11306106 Xofluza method of use 70 2037-08-09
11306106 Xofluza method of use 70 2037-08-09
11306106 Xofluza method of use 70 2037-08-09
10633397 Xofluza method of use 62 2036-04-27
10633397 Xofluza method of use 62 2036-04-27

Strongest defences

Lowest vulnerability scores — pillars of the indication's IP fortress.

Patent Drug Type Vuln Expiry
10759814 Xofluza composition of matter 4 2037-08-09
10759814 Xofluza composition of matter 4 2037-08-09
10759814 Xofluza composition of matter 4 2037-08-09
10759814 Xofluza composition of matter 4 2037-08-09
10392406 Xofluza composition of matter 4 2036-04-27
10392406 Xofluza composition of matter 4 2036-04-27
10392406 Xofluza composition of matter 4 2036-04-27
10392406 Xofluza composition of matter 4 2036-04-27
8987441 Xofluza composition of matter 4 2032-10-24
8987441 Xofluza composition of matter 4 2032-10-24

Related